OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Biosimilars in the treatment of rheumatoid arthritis: a pharmacokinetic overview
Yeo‐Jin Song, Seoung Wan Nam, Chang‐Hee Suh, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 11, pp. 751-768
Closed Access | Times Cited: 6
Yeo‐Jin Song, Seoung Wan Nam, Chang‐Hee Suh, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 11, pp. 751-768
Closed Access | Times Cited: 6
Showing 6 citing articles:
Analysis of biosimilars consumption in an Italian Local Health Authority
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 5317-5323
Closed Access | Times Cited: 5
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 7, pp. 5317-5323
Closed Access | Times Cited: 5
Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer
Michael Croft, Shahram Salek‐Ardakani, Carl F. Ware
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 939-961
Closed Access | Times Cited: 5
Michael Croft, Shahram Salek‐Ardakani, Carl F. Ware
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 939-961
Closed Access | Times Cited: 5
Monitoring analysis of the use of biosimilar medicines in the Campania region (southern Italy) to support effective and sustainable care
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
Wiener Medizinische Wochenschrift (2025) Vol. 175, Iss. 5-6, pp. 128-134
Closed Access
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
Wiener Medizinische Wochenschrift (2025) Vol. 175, Iss. 5-6, pp. 128-134
Closed Access
What's new on the horizon for rheumatoid arthritis management
Karmtej Singh Cheema, Ali Mansour, Siba P. Raychaudhuri
Best Practice & Research Clinical Rheumatology (2025), pp. 102038-102038
Closed Access
Karmtej Singh Cheema, Ali Mansour, Siba P. Raychaudhuri
Best Practice & Research Clinical Rheumatology (2025), pp. 102038-102038
Closed Access
Analysis of prescriptive monitoring regarding the current therapeutic landscape of rheumatoid arthritis: the experience of an Italian local health authority
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024), pp. 1-7
Closed Access | Times Cited: 1
Francesco Ferrara, Andrea Zovi, Roberto Langella, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2024), pp. 1-7
Closed Access | Times Cited: 1
The use of the biosimilar drug can lead to large health care savings that can be reinvested for continued innovation: Analysis of consumption of an Italian health care company
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Journal of Cancer Policy (2024) Vol. 40, pp. 100473-100473
Closed Access
Francesco Ferrara, Maurizio Capuozzo, Roberto Langella, et al.
Journal of Cancer Policy (2024) Vol. 40, pp. 100473-100473
Closed Access
Non-TNF biologics and their biosimilars in rheumatoid arthritis
Tsz Ching Mok, Chi Chiu Mok
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 7, pp. 599-613
Closed Access
Tsz Ching Mok, Chi Chiu Mok
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 7, pp. 599-613
Closed Access
